Charles River Laboratories Intl (CRL)

Jan 16, 2025, 8:00 AM EST - 1 day ago

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform

Jan 13, 2025, 8:00 AM EST - 4 days ago

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

Jan 7, 2025, 8:00 AM EST - 10 days ago

Deciphex Secures $32.3M Series C to Address Global Pathology Shortage

Dec 20, 2024, 7:51 AM EST - 4 weeks ago

Tax-related selling is hitting these 7 stocks — but their loss could be your gain

AVNW CVS DLHC FL VAL

Dec 5, 2024, 8:00 AM EST - 6 weeks ago

Charles River Introduces Global Biotech Incubator Program

Dec 2, 2024, 8:00 AM EST - 6 weeks ago

Charles River Laboratories to Present at Evercore ISI Investor Conference

Nov 11, 2024, 8:00 AM EST - 2 months ago

Charles River Laboratories to Present at UBS and Jefferies Conferences

Nov 6, 2024, 6:51 PM EST - 2 months ago

Charles River Laboratories International, Inc. (CRL) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 8:30 AM EST - 2 months ago

Charles River Laboratories raises annual profit forecast on stabilizing biotech demand

Nov 6, 2024, 7:00 AM EST - 2 months ago

Charles River Laboratories Announces Third-Quarter 2024 Results

Oct 17, 2024, 8:00 AM EDT - 3 months ago

Charles River Launches New Retrogenix® Non-Human Protein Library

Oct 16, 2024, 4:30 PM EDT - 3 months ago

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call

Oct 8, 2024, 11:26 AM EDT - 3 months ago

Operadora de Fondos Banorte Adopts Charles River's Cloud-Based Platform

Oct 3, 2024, 8:00 AM EDT - 3 months ago

Charles River Provides Translational Expertise at Neuroscience 2024

Oct 2, 2024, 8:00 AM EDT - 3 months ago

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease

Sep 19, 2024, 6:00 AM EDT - 4 months ago

Xspray Pharma Announces Positive FDA Meeting and Plans for Dasynoc NDA Resubmission

Sep 18, 2024, 8:30 AM EDT - 4 months ago

Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing

Sep 17, 2024, 8:00 AM EDT - 4 months ago

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research

Sep 4, 2024, 8:00 AM EDT - 4 months ago

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

Sep 3, 2024, 4:30 PM EDT - 4 months ago

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Aug 15, 2024, 6:31 AM EDT - 5 months ago

Charles River Laboratories: Changing Economics Reduces Compounding Ability (Rating Downgrade)

Aug 10, 2024, 9:00 AM EDT - 5 months ago

Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)

Aug 7, 2024, 2:21 PM EDT - 5 months ago

Charles River Laboratories International Inc (CRL) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 1:31 PM EDT - 5 months ago

Charles River Labs Says It Expects Sales To Fall, Sending Its Stock Tumbling

Aug 7, 2024, 10:06 AM EDT - 5 months ago

Charles River Laboratories Stock Sinks As It Warns Of Continued Biotech Demand Slump, Lowers Forecast

Aug 7, 2024, 8:26 AM EDT - 5 months ago

Charles River cuts 2024 forecast as funding crunch among biotech clients persists

Aug 7, 2024, 7:00 AM EDT - 5 months ago

Charles River Laboratories Announces Second-Quarter 2024 Results

Jul 30, 2024, 8:00 AM EDT - 6 months ago

Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development

Jul 24, 2024, 8:00 AM EDT - 6 months ago

Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery

Jul 16, 2024, 4:30 PM EDT - 6 months ago

Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call

Jul 8, 2024, 8:00 AM EDT - 6 months ago

Charles River to Perform Plasmid Manufacturing for AAVantgarde

Jun 25, 2024, 8:00 AM EDT - 7 months ago

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus

Jun 17, 2024, 8:00 AM EDT - 7 months ago

Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy

Jun 14, 2024, 1:27 PM EDT - 7 months ago

A.I. Impact On Biopharma: LLY, AMGN, TMO, CRL

LLY AMGN TMO

Jun 11, 2024, 8:00 AM EDT - 7 months ago

Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives

Jun 6, 2024, 8:00 AM EDT - 8 months ago

Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville

Jun 4, 2024, 8:00 AM EDT - 8 months ago

Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research

Jun 3, 2024, 8:00 AM EDT - 8 months ago

Charles River Laboratories to Present at William Blair and Jefferies Conferences

May 31, 2024, 4:44 AM EDT - 8 months ago

Charles River Laboratories: Fair Valuation Against Fundamentals

May 30, 2024, 8:00 AM EDT - 8 months ago

Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development

May 28, 2024, 4:12 AM EDT - 8 months ago

Titian Receives Multi-Year Commitment from Charles River for Mosaic Sample Management Software

May 9, 2024, 7:00 AM EDT - 9 months ago

Charles River Laboratories Announces First-Quarter 2024 Results

May 2, 2024, 8:00 AM EDT - 9 months ago

Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP

Apr 22, 2024, 8:00 AM EDT - 9 months ago

Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally

Apr 16, 2024, 8:00 AM EDT - 9 months ago

Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing

Apr 12, 2024, 8:00 AM EDT - 10 months ago

Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call

Apr 11, 2024, 8:00 AM EDT - 10 months ago

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

Apr 9, 2024, 8:00 AM EDT - 10 months ago

Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics